These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Mental deterioration in arteriosclerotic subjects before and after treatment with SP 54 and with a placebo]. Buffa B; Cotta Ramusino M; Muti M Riv Sper Freniatr Med Leg Alien Ment; 1969 Feb; 93(1):209-18. PubMed ID: 5402879 [No Abstract] [Full Text] [Related]
24. [Therapy of arteriosclerotic vasculopathies with arterial wall extract]. Veccia F Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689 [No Abstract] [Full Text] [Related]
25. [Arteriosclerosis and fibrinolysis]. Matsuda T Nihon Rinsho; 1973 Apr; 31(4):836-43. PubMed ID: 4580400 [No Abstract] [Full Text] [Related]
26. [Preliminary clinical uses of aspirin as an anticoagu.ant. (Preliminary note)]. Cavalieri U; Quadri A; Tammaro AE Policlinico Prat; 1970 Dec; 77(51):1666-70. PubMed ID: 5516120 [No Abstract] [Full Text] [Related]
27. The effect of coumarin-type anticoagulants on blood fibrinolysis. Moellering RC; Rosenblatt G; Bassett DR; Stokes J Hawaii Med J; 1968; 28(1):29-32. PubMed ID: 5706530 [No Abstract] [Full Text] [Related]
28. [Prolonged therapeutic-prophylactic use of anticoagulants]. Kushelevskiĭ BP; Seliverstova GP Klin Med (Mosk); 1973 Apr; 51(4):26-8. PubMed ID: 4704262 [No Abstract] [Full Text] [Related]
29. [Behavior of the thromboelastogram (TEG) in arteriosclerotic subjects treated with natural mucopolysaccharide substances]. Garbagnati N; Iaschi P; Ciavarelli F; Carignola W Clin Ter; 1969 Jul; 50(2):125-31. PubMed ID: 4243098 [No Abstract] [Full Text] [Related]
30. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study]. Ciammaichella A; Solitro A; Arcuri P Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771 [No Abstract] [Full Text] [Related]
31. [Administration of synanthrin in therapy of coronary atherosclerosis]. Zolotarev AE Fiziol Zh; 1970; 16(5):685-6. PubMed ID: 5507977 [No Abstract] [Full Text] [Related]
32. [The use in geriatrics of a preparation with antisclerotic action. (Preliminary results)]. Solaro F; Corletto F; Dinale M G Gerontol; 1969 Aug; 17(8):801-7. PubMed ID: 5371743 [No Abstract] [Full Text] [Related]
33. [Prevention and therapy of peripheral arteriosclerotic circulatory disorders using anticoagulants]. Egghart F Wien Med Wochenschr; 1973 Apr; 123(16):259-60. PubMed ID: 4701667 [No Abstract] [Full Text] [Related]
34. [Experience with the use of papaverolina in patients with arterial diseases]. Patrignani S; Graziani A; Ranieri A; Russo O Clin Ter; 1981 Jun; 97(5):495-519. PubMed ID: 7273660 [No Abstract] [Full Text] [Related]
35. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology]. Ciammaichella A; Solitro A; Torcia L; Arcuri P Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104 [No Abstract] [Full Text] [Related]
36. [Treatment of chronic cerebral circulatory insufficiency]. Vayron de la Moureyre D Lille Med; 1968 Jan; 13(1):76-80. PubMed ID: 5744744 [No Abstract] [Full Text] [Related]
37. [Effect of lumbar sympathectomy on peripheral circulation]. Dobromyslova OP; Lesniak GP; Pokrovskaia LA Fiziol Zh SSSR Im I M Sechenova; 1980 Jul; 66(7):1101-6. PubMed ID: 7409266 [No Abstract] [Full Text] [Related]